NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

NIH Research News


Key: Meeting M      Journal J      Funder F

Showing releases 76-84 out of 84.

<< < 1 | 2 | 3 | 4

Public Release: 24-Sep-2014
Emerging Infectious Diseases
NIH study supports camels as primary source of MERS-CoV transmission
NIH and Colorado State University scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus. The study, designed by scientists from CSU and NIH's National Institute of Allergy and Infectious Diseases, involved three healthy camels exposed through the eyes, nose and throat to MERS-CoV isolated from a patient. Each camel developed a mild upper respiratory tract infection consistent with what scientists have observed throughout the Middle East.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 24-Sep-2014
NIH announces network to accelerate medicines for rheumatoid arthritis and lupus
The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network.
National Institutes of Health, AbbVie, Bristol-Myers Squibb, Merck, Pfizer, Sanofi, Takeda, the Arthritis Foundation, the Lupus Foundation of America, the Lupus Research Institute/Alliance for Lupus Research, and the Rheumatology Research Foundation.

Contact: Trish Reynolds
reynoldsp2@mail.nih.gov
301-496-8190
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Public Release: 23-Sep-2014
NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain
NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain
The National Institutes of Health is convening a Pathways to Prevention workshop to assess the available scientific evidence on the long-term effectiveness and potential risks of opioids for treating chronic pain. Participants will be among the nation's top experts in the field of pain control and management from around the country, as well as key NIH scientists who focus on pain related research. An impartial, independent panel will identify research gaps and future research priorities.

Contact: Deborah Langer
langerdh@od.nih.gov
301-443-4569
NIH/Office of Disease Prevention

Public Release: 23-Sep-2014
NIH funds next phase of Tissue Chip for Drug Screening program
The National Institutes of Health will award funds to support the next phase of its Tissue Chip for Drug Screening program to improve ways of predicting drug safety and effectiveness. Researchers will collaborate over three years to refine existing 3-D human tissue chips and combine them into an integrated system that can mimic the complex functions of the human body.
National Institutes of Health

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-435-0888
NIH/National Center for Advancing Translational Sciences (NCATS)

Public Release: 23-Sep-2014
New supplemental awards apply sex and gender lens to NIH-funded research
The National Institutes of Health has awarded $10.1 million in supplemental funding to bolster the research of 82 grantees to explore the effects of sex in preclinical and clinical studies.
National Institutes of Health

Contact: Anne Rancourt
anne.rancourt@nih.gov
301-451-7058
NIH/Office of the Director

Public Release: 12-Sep-2014
NIH awards aim to improve understanding of cell pathways, development of new therapies
National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses, the Library of Integrated Network-based Cellular Signatures. Discovering such cell responses will improve scientists' understanding of cell pathways and aid in the development of new therapies for many diseases.
NIH/Common Fund, NIH/National Institute of Neurological Disorders and Stroke

Contact: Steven Benowitz
steven.benowitz@nih.gov
301-451-8325
NIH/National Human Genome Research Institute

Public Release: 9-Sep-2014
NIH launches online database of international clinical research regulations
The National Institutes of Health (NIH) today launched ClinRegs, an online public database of country-specific clinical research regulatory information. The ClinRegs website, created and maintained by NIH's National Institute of Allergy and Infectious Diseases, enables users to explore and compare regulations across different countries.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Hillary Hoffman
hillary.hoffman@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Sep-2014
Molecular Psychiatry
Eating habits, body fat related to differences in brain chemistry
People who are obese may be more susceptible to environmental food cues than their lean counterparts due to differences in brain chemistry that make eating more habitual and less rewarding, according to a National Institutes of Health study published in Molecular Psychiatry.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases, NIH/National Institute of Mental Health

Contact: Krysten Carrera
NIDDKMedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Public Release: 8-Sep-2014
Nature Medicine
Rapid and durable protection against ebola virus with new vaccine regimens
One shot of an experimental vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector, called chimp adenovirus type 3 or ChAd3, protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation, report National Institutes of Health scientists and their collaborators.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Showing releases 76-84 out of 84.

<< < 1 | 2 | 3 | 4

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2015 by AAAS, the science society.